0001387131-22-007441.txt : 20220701
0001387131-22-007441.hdr.sgml : 20220701
20220701160523
ACCESSION NUMBER: 0001387131-22-007441
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220629
FILED AS OF DATE: 20220701
DATE AS OF CHANGE: 20220701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEDERMAN SETH
CENTRAL INDEX KEY: 0001563420
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36019
FILM NUMBER: 221061370
MAIL ADDRESS:
STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP
STREET 2: 509 MADISON AVE., SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp.
CENTRAL INDEX KEY: 0001430306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261434750
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 MAIN STREET, SUITE 101
CITY: CHATHAM
STATE: NJ
ZIP: 07928
BUSINESS PHONE: 212-980-9155
MAIL ADDRESS:
STREET 1: 26 MAIN STREET, SUITE 101
CITY: CHATHAM
STATE: NJ
ZIP: 07928
FORMER COMPANY:
FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC.
DATE OF NAME CHANGE: 20080320
4
1
lederman-form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
X0306
4
2022-06-29
0
0001430306
Tonix Pharmaceuticals Holding Corp.
TNXP
0001563420
LEDERMAN SETH
C/O TONIX PHARMACEUTICALS HOLDING CORP
26 MAIN STREET, SUITE 101
CHATHAM
NJ
07928
1
1
0
0
Chief Executive Officer
Common Stock, $0.001 par value
2022-06-29
4
P
0
20000
1.71
A
24235
I
By IRA Account
Common Stock, $0.001 par value
3505
D
Common Stock, $0.001 par value
1
I
By spouse
Common Stock, $0.001 par value
1
I
By Leder Laboratories, Inc.
Common Stock, $0.001 par value
1
I
By Starling Pharmaceuticals, Inc.
Common Stock, $0.001 par value
7
I
By Lederman & Co., LLC
Common Stock, $0.001 par value
2
I
By L&L Technologies, LLC
Common Stock, $0.001 par value
2
I
By Targent Pharmaceuticals, LLC
Shares reported reflect a 1-for-32 reverse stock split effective May 17, 2022.
Reporting person may be deemed to be a control person of this entity.
/s/ Seth Lederman
2022-07-01